Investing Profile

Elena Viboch

InvestorVC

Managing Director at General Catalyst

generalcatalyst.comSan Francisco Bay Area

Your Intro Paths to Elena Viboch

Signal uses Gmail to reveal intro paths. Email content is never read.

Elena Viboch's investing connections

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (Pivotal bioVenture Partners).

Networks Elena is a member of

NewCo Network

1599 CONNECTIONS

NewCo Network

1599 CONNECTIONS

Top-Patents Network

1033 CONNECTIONS

Top-Patents Network

1033 CONNECTIONS

BlueStone Capital Partners, L.P. Network

432 CONNECTIONS

Find Elena Viboch on

Current Investing Position

General Catalyst Managing Director

Investment Range

$500K - $2.0M

Sweet Spot

$500K

Investments On Record

Current Fund Size

$1.1B

Elena Viboch is on these Sector & Stage Rankings

BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series A)San Francisco Bay Area Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Elena Viboch's Investments On Record (21)

Company	StageDateRound Size	Total Raised
Parabilis Medicines	Series FJan 2026$310M Series EMar 2024$150M	$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Corey Goodman (venBio), Thilo Schroeder (Nextech Invest), Jake Simson (RA Capital Management)
Chai Discovery	Series BDec 2025$130M	$230M
Co-investors: Hemant Taneja (General Catalyst), Fred Ehrsam (Paradigm), Greg Yap (Menlo Ventures), Nitesh Banta (Stellar Capital), Lachy Groom (Physical Intelligence), Annie Lamont (Oak HC/FT)
Paradigm	Series BDec 2025$78M Series AJan 2023$200M	$320M
Co-investors: Hemant Taneja (General Catalyst), David Schenkein (GV (Google Ventures)), Niko Bonatsos (General Catalyst), Ramnik Arora (FTX Ventures), Max Rimpel (Index Ventures), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Eoghan McCabe (Spark-Local, Inc), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa (Vir Biotechnology, Inc.), Justin Kao (DFJ Growth), Jared Friedman (Israel Defense Forces), Scott Belsky (capitalB), Balaji Srinivasan, Karim Atiyeh, Arash Ferdowsi
Tahoe Therapeutics	Series AAug 2025$30M SeedDec 2022$12M	$42M
Co-investors: Gaurav Garg (Wing Venture Capital), Deep Nishar (SoftBank Investment Advisers), Krish Ramadurai (Harmonix Fund), Sunil Dhaliwal (Amplify Partners), Ayman AlAbdallah
Maxion Therapeutics	Series AMar 2025$75M	$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Eikon Therapeutics	Series DFeb 2025$350M Series BJan 2022$520M	$1B
Co-investors: Josh Wolfe (Lux Capital), Adam Goulburn (Dimension Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Manas AI	SeedJan 2025$25M	$25M
Co-investors: Hemant Taneja (General Catalyst), Reid Hoffman (Greylock)
Medeloop	Series ANov 2024$16M SeedSep 2023$8M	$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)